1
|
di Russo P, Fava A, Vandenbulcke A, Miyakoshi A, Kohno M, Evins AI, Esposito V, Morace R. Characteristics and management of hydrocephalus associated with vestibular schwannomas: a systematic review. Neurosurg Rev 2020; 44:687-698. [PMID: 32266553 DOI: 10.1007/s10143-020-01287-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2020] [Revised: 02/23/2020] [Accepted: 03/16/2020] [Indexed: 10/24/2022]
Abstract
Hydrocephalus (HC) can be associated with vestibular schwannoma (VS) at presentation. Although spontaneous resolution of HC after VS removal is reported, first-line treatment is varied including preoperative ventriculoperitoneal (VP) shunt, external ventricular drainage (EVD), or lumbar drainage (LD). We performed a systematic review to clarify optimal management of HC associated with VS at presentation, as well as characteristics of patients with initial and persistent HC after VS removal, and prevalence of HC associated with VS. Fourteen studies were included. Patients were grouped according to the timing of HC treatment. The overall rate of VP shunts was 19.4%. Among patients who received VS removal as first-line treatment, 6.9% underwent permanent shunts. In a subgroup of 132 patients (studies with no-aggregate data), t test analysis for mean tumor size (P = 0.02) and mean CSF protein level (P < 0.001) demonstrated statistically significant differences between patients with resolved HC (3.48 cm and 201 mg/dL) and patients with persistent HC (2.46 cm and 76.8 mg/dL) after VS resection. Transient treatment of HC using EVD or LD further resolved the HC in 87.5% and 82.9% of patients, respectively, before and after VS removal. The overall prevalence of HC associated with VS in a population of 2336 patients was 9.3%. Schwannoma removal as first-line treatment is justified by its low rate of persistent HC requiring VP shunt (roughly 7%). Patients with smaller VS and lower CSF proteins present higher risk of persistent HC after schwannoma removal. Temporary treatment of HC contributes to its resolution, both before and after VS removal.
Collapse
Affiliation(s)
- Paolo di Russo
- Department of Neurosurgery, I.R.C.C.S. Neuromed, Via Atinense 18, 86077, Pozzilli, (IS), Italy.
| | - Arianna Fava
- Department of Neurosurgery, I.R.C.C.S. Neuromed, Via Atinense 18, 86077, Pozzilli, (IS), Italy
| | - Alberto Vandenbulcke
- Department of Neurosurgery, I.R.C.C.S. Neuromed, Via Atinense 18, 86077, Pozzilli, (IS), Italy
| | - Akinori Miyakoshi
- Department of Neurosurgery, Shizuoka General Hospital, Shizuoka, Japan
| | - Michihiro Kohno
- Department of Neurosurgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan
| | - Alexander I Evins
- Department of Neurological Surgery, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA
| | - Vincenzo Esposito
- Department of Neurosurgery, I.R.C.C.S. Neuromed, Via Atinense 18, 86077, Pozzilli, (IS), Italy.,Department of Human Neuroscience, Sapienza - University of Rome, Rome, Italy
| | - Roberta Morace
- Department of Neurosurgery, I.R.C.C.S. Neuromed, Via Atinense 18, 86077, Pozzilli, (IS), Italy
| |
Collapse
|
2
|
Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review. Neurosurg Rev 2017; 41:957-968. [PMID: 28265819 DOI: 10.1007/s10143-017-0839-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2016] [Revised: 02/18/2017] [Accepted: 02/21/2017] [Indexed: 10/20/2022]
Abstract
Phacomatoses are a special group of familial hamartomatous syndromes with unique neuro-cutaneous manifestations as well as disease characteristic tumors. Neurofibromatosis 2 (NF2) and tuberous sclerosis complex (TSC) are representatives of this family. Vestibular schwannoma (VS) and subependymal giant cell tumor (SGCT) are two of the most common intracranial tumors associated with NF2 and TSC, respectively. These tumors can present with obstructive hydrocephalus due to their location adjacent to or in the ventricles. However, both tumors are also known to have a unique association with an elevated protein concentration in the cerebrospinal fluid (CSF), sometimes in association with non-obstructive (communicating) hydrocephalus (HCP), the causality of which has been unclear. Furthermore, SGCTs have repeatedly been shown to have a predisposition for CSF clotting, causing debilitating obstructions and recurrent malfunctions in shunted patients. However, the exact relation between high protein levels and spontaneous clotting of the CSF is not clear, nor is the mechanism understood by which CSF may clot in SGCTs. Elevated protein levels in the CSF are thought to be caused by increased vascular permeability and dysregulation of the blood-brain barrier. The two presumed underlying pathophysiologic mechanisms for that, in the context of tumorigenesis, are angiogenesis and inflammation. Both mechanisms are correlated to the Pi3K/Akt/mTOR pathway which is a major tumorigenesis pathway in nearly all phacomatoses. In this review, we discuss the influence of angiogenesis and inflammation on vascular permeability in VSs and SGCTs at the phenotypic level as well as their possible genetic and molecular determinants. Part I describes the historical perspectives and clinical aspects of the relationship between vascular permeability, abnormal CSF protein levels, clotting of the CSF, and communicating HCP. Part II describes different cellular and molecular pathways involved in angiogenesis and inflammation in these two tumors and the correlation between inflammation and coagulation. Interestingly, while increased angiogenesis can be observed in both VS and SGCT, inflammatory processes seem more prominent in SGCT. Both pathologies are characterized by different subgroups of tumor-associated macrophages (TAM): the pro-inflammatory, M1 type is predominating in SGCTs while pro-angiogenetic, M2 type is predominating in VSs. We suggest that lack of NF2 protein in VS and lack of TSC1/2 proteins in SGCT determine this fundamental difference between the two tumor types, by defining the predominant TAM type. Since inflammatory reactions and coagulation processes are tightly connected, a "pro-inflammatory state" of SGCT can be used to explain the observed associated enhanced CSF clotting process. These distinct cellular and molecular differences may have direct therapeutic implications on tumors that are unique to certain phacomatoses or those with similar genetics.
Collapse
|
3
|
Al Hinai Q, Zeitouni A, Sirhan D, Sinclair D, Melancon D, Richardson J, Leblanc R. Communicating hydrocephalus and vestibular schwannomas: etiology, treatment, and long-term follow-up. J Neurol Surg B Skull Base 2013; 74:68-74. [PMID: 24436891 DOI: 10.1055/s-0033-1333621] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2012] [Accepted: 10/24/2012] [Indexed: 10/27/2022] Open
Abstract
Background Large vestibular schwannomas (VSs) can cause hydrocephalus by obstructing the fourth ventricle. Little is known about the communicating hydrocephalus that is seen with a smaller VS. Methods The clinicopathological findings and follow up of three patients with communicating hydrocephalus associated with a small VS are presented. Results Four patients aged 40 to 66 years (mean: 57.7) presented with ataxia, dementia, and urinary incontinence. The VS were 2.0 to 2.4 cm. The cerebrospinal fluid (CSF) protein was elevated in three patients in whom it was measured (1.7 to 6 times normal). The VS was resected in two patients. All of the patients required ventriculoperitoneal shunting (VPS). All of the patients were asymptomatic or improved at follow-up at 9 months to 13 years. Conclusion Communicating hydrocephalus associated with a VS can occur in younger patients than was previously thought. An elevated CSF protein appears to be important, but other factors may be involved. A shunting procedure is often required to relieve the symptoms of hydrocephalus even if the tumor is resected. Possible etiological causes of communicating hydrocephalus in patients with a small VS are discussed.
Collapse
Affiliation(s)
- Qasim Al Hinai
- Department of Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| | - Anthony Zeitouni
- Department of Otolaryngology, McGill University, Montréal, Québec, Canada
| | - Denis Sirhan
- Department of Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| | - David Sinclair
- Department of Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| | - Denis Melancon
- Department of Diagnostic Neuroradiology, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| | - John Richardson
- Department of Neuropathology, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| | - Richard Leblanc
- Department of Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada
| |
Collapse
|